Supplementary Methods S6 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study | Synapse
June 3, 2024Open Access
Supplementary Methods S6 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Supplementary Methods 6. Functional categories and related numbers of genes profiled using the NanoString PanCancer Immune panel.